Cardiovascular health deteriorates significantly during perimenopause, with women in this transition phase showing twice the odds of poor cardiometabolic scores compared to premenopausal women. This critical window presents an opportunity for early intervention before postmenopausal decline solidifies, particularly through metabolic monitoring and dietary optimization.
Key Points
- Perimenopausal women show 2x odds of poor cardiovascular scores versus premenopausal women
- Blood lipid and glucose markers decline 76-83% more sharply during perimenopause transition
- Diet quality lowest across all groups; nutrition emerges as primary intervention target
Longevity Analysis
Perimenopause represents a critical inflection point in female cardiometabolic aging, where hormonal flux amplifies cardiovascular risk before postmenopausal stabilization. Early detection and intervention during this transition—before established disease patterns consolidate—offers a measurable window to alter long-term cardiovascular trajectory. The data suggests this period demands proactive metabolic surveillance and dietary restructuring rather than reactive management after menopause, fundamentally shifting the timing of health optimization for midlife women.
Original published by LifeSpan.io, by Anna Drangowska-Way.